Clinical Trial Update: Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating overnight switch from immediate-release to extended-release pramipexole in early Parkinson's disease; results completed and posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Pramipexole ER (pramipexole)
• Pramipexole IR (pramipexole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Parkinson Disease | Phase 3 | Status: COMPLETED | Results posted: 2009-11-20